Nos1: Difference between revisions

From Proteopedia
Jump to navigationJump to search
No edit summary
No edit summary
Line 9: Line 9:
2 L-arginine + 3 NADPH + 4 O(2) = 2 L- citrulline + 2 nitric oxide + 3 NADP(+) + 4 H(2)O
2 L-arginine + 3 NADPH + 4 O(2) = 2 L- citrulline + 2 nitric oxide + 3 NADP(+) + 4 H(2)O


Nitric oxide is used in a wide variety of processes. A few examples of molecular processes include heme binding, NADP binding, calcium signaling, and oxidation-reduction reactions. Biological examples include regulation of cardiac muscle contraction, blood coagulation, aging, and regulation of neurogenesis. There are five known isoforms known for NOS1 in humans produced by alternative splicing, which are expressed at different levels as denoted by microarray data. Please note that microarray data is only available for isoforms 1, 3, and 4.
Nitric oxide is used in a wide variety of processes. A few examples of molecular processes include heme binding, NADP binding, calcium signaling, and oxidation-reduction reactions. Biological examples include regulation of cardiac muscle contraction, blood coagulation, aging, and regulation of neurogenesis. There are three known isoforms known for NOS1 in humans produced by alternative splicing. These isoforms are reffered to as neuronal NOS (nNOS), endothelial NOS (eNOS), and cytokine-inducible NOS (iNOS).  


Tissue         Isoform 1 Isoform 3 Isoform 4
Skeletal muscle Moderate N/A         Moderate
Brain          Moderate N/A         Low
Testis         Moderate Moderate Moderate
Lung         Moderate N/A         Moderate
Kidney         Moderate N/A         Moderate
Heart         Low         N/A         N/A
Adrenal gland Low         N/A         N/A
Retina         Low         N/A         N/A


[[Image:expression table snip.jpg]]
== Function ==
== Function ==



Revision as of 18:35, 12 April 2016

Your Heading Here (maybe something like 'Structure')

Caption for this structure

Drag the structure with the mouse to rotate

References

Proteopedia Page Contributors and Editors (what is this?)

Mark T. Hilliard, Michal Harel